CTRI gets patent for Solansole
Central Tobacco Research Institute (CTRI) based in Guntur in the southern Indian state of Andhra Pradesh has bagged the patent rights for for ‘solansole’ (a medicine extracted from tobacco for use in the manufacture of cancer and cardiac drugs). As per MedIndia news Chinese producer Nanjing Huaguan Development Of Biotechnology Co is the major global supplier.
No comments:
Post a Comment